Michael Goldstein, Ph.D. has a background in Physics and Computer Engineering. Michael founded Rx Analytic, Inc. where Michael and their team developed drug delivery technology. Prior to that, Michael worked as a Sr. Principal Engineer at Intel Corporation. Michael also served as the EUV Mask Infrastructure Partnership and AIMS EUV Program Manager at SEMATECH. Currently, Michael holds the position of Principal Researcher at ASML.
January, 2022 - present